Casandra
Casandra Test Code QD51993Version 1 (DRAFT)
Performing Lab
Aspergillus Antigen, EIA, BAL
Also known as: Platelia® Aspergillus Antigen, Galactomannan Antigen
Clinical Use
Order TestUse
Invasive pulmonary aspergillosis is a serious fungal infection commonly affecting immunocompromised patients. Detection of Aspergillus galactomannan antigen in bronchoalveolar lavage (BAL) fluid by enzyme immunoassay aids in early diagnosis when correlated with other clinical and microbiological findings. ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/prismahealth/test/909797?utm_source=openai))
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (EIA)
Biomarkers
Aspergillus galactomannan antigen
AnalyteIndex Value • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Bronchoalveolar Lavage
Volume
2 mL preferred, minimum 1 mL
Minimum Volume
1 mL
Container
Sterile container
Storage Instructions
Refrigerated (cold packs)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 5 days (unopened) |
Related Tests
Other tests from different labs that may be relevant